— Know what they know.
Not Investment Advice

CBDD OTC

CBD of Denver, Inc.
1W: +9900.0% 1M: +9900.0% 3M: +0.0% YTD: -33.3% 1Y: -33.3% 3Y: -88.9% 5Y: -98.7%
$0.00
-0.00 (-25.93%)
 
Weekly Expected Move ±9293.7%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 60 · $1.1M mcap · Short 67% of daily vol

Cash Flow Trends

Operating Cash Flow
-$88K -179.4% ▼
Capital Expenditures
$3 -175.0% ▼
Free Cash Flow
-$88K -179.4% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$1K -116.8% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$779K-$236K-$3M$584K-$80K
Depreciation & Amort.$3K$0$0$0$11K
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital-$764K-$489K$2M-$712K-$19K
Other Non-Cash Items$43K$2K$507K$97K$0
Operating Cash Flow$61K-$724K-$759K-$31K-$88K
— Investing Activities —
Capital Expenditures$0$0$0$4$0
Acquisitions (Net)$0$0$0$11K$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$16K$0$0-$4$0
Investing Cash Flow-$16K$0$0$11K$0
— Financing Activities —
Net Debt Issuance$0$855K$421K$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$0$0
Financing Cash Flow$310$855K$731K$11K$86K
Net Change in Cash$45K$9K-$63K$9K-$1K
Cash End of Period$83K$92K$28K$37K$35K
Free Cash Flow$61K-$724K-$759K-$31K-$88K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms